These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1137681)

  • 1. Proceedings: Biological and pharmacological myocardial elimination rate of propranolol.
    Coltart J
    Br Heart J; 1975 May; 37(5):555. PubMed ID: 1137681
    [No Abstract]   [Full Text] [Related]  

  • 2. Myocardial sensitivity to isoproterenol following abrupt propranolol withdrawal in conscious dogs.
    Webb JG; Newman WH; Walle T; Daniell HB
    J Cardiovasc Pharmacol; 1981; 3(3):622-35. PubMed ID: 6168842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time required for complete recovery from chronic propranolol therapy.
    Faulkner SL; Hopkins JT; Boerth RC; Young JL; Jellett LV; Nies AS; Bender HW; Shand DG
    N Engl J Med; 1973 Sep; 289(12):607-9. PubMed ID: 4541874
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of isoproterenol and some other drugs on high energy phosphate metabolism in rat myocardium.
    Takenaka F
    Recent Adv Stud Cardiac Struct Metab; 1975; 6():151-8. PubMed ID: 1197877
    [No Abstract]   [Full Text] [Related]  

  • 5. [Changes of myocardial adenine-nucleotide synthesis through isoproterenol and propranolol].
    Zimmer HG; Steinkopff G; Gerlach E
    Verh Dtsch Ges Kreislaufforsch; 1973; 39():183-8. PubMed ID: 4785924
    [No Abstract]   [Full Text] [Related]  

  • 6. Isoproterenol myocytolysis and myocardial calcium.
    Bloom S; Davis D
    Recent Adv Stud Cardiac Struct Metab; 1974; 4():581-90. PubMed ID: 4468469
    [No Abstract]   [Full Text] [Related]  

  • 7. Glucagon and isoproterenol in reversing propranolol toxicity.
    Kosinski EJ; Malindzak GS
    Arch Intern Med; 1973 Dec; 132(6):840-3. PubMed ID: 4757253
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of obzidan and Novodrin on the phospholipid composition of the myocardium].
    Ovchinnikov IV
    Farmakol Toksikol; 1983; 46(5):37-40. PubMed ID: 6628658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between sympathomimetic agonists and blocking agents: cardiac effects of phenylephrine and isoproterenol.
    Márquez MT; Mikulić LE; Aramendía P
    Methods Find Exp Clin Pharmacol; 1981; 3(5):283-9. PubMed ID: 7329156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uptake of propranolol by isolated guinea-pig atria.
    Potter LT
    J Pharmacol Exp Ther; 1967 Jan; 155(1):91-100. PubMed ID: 6017346
    [No Abstract]   [Full Text] [Related]  

  • 11. Proceedings: Effects of isoproterenol and its antagonist on myocardial lipid metabolism.
    Takeo S; Higuchi M; Watanabe A; Araki H; Takenaka F
    Jpn J Pharmacol; 1974; 24(0):s:75. PubMed ID: 4545971
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of isoprenaline, propranolol and alprenolol on the glycogen phosphorylase activity and glycogen level of the heart of neonate and adult rats.
    Brus R
    Pol J Pharmacol Pharm; 1973; 25(5):423-8. PubMed ID: 4777345
    [No Abstract]   [Full Text] [Related]  

  • 13. Beta adrenergic blockade with propranolol in conscious euthyroid and thyrotoxic calves: dosage requirements and effects on heart rate and left ventricular performance.
    Goldman S; Olajos M; Pieniaszek H; Perrier D; Mayersohn M; Morkin E
    J Pharmacol Exp Ther; 1981 Nov; 219(2):394-9. PubMed ID: 7288628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoproterenol-produced damage in amphibian heart could be mediated by adrenergic receptors located in the heart muscle.
    Cano-Martínez A; Vargas-González A; Guarner-Lans V; Prado-Zayago E
    Proc West Pharmacol Soc; 2004; 47():63-6. PubMed ID: 15633614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical basis of the protective effect of propranolol pretreatment in experimental myocardial necrosis.
    Gupta MP; Manchanda SC; Seth SD
    Indian J Exp Biol; 1982 Jan; 20(1):79-83. PubMed ID: 7118200
    [No Abstract]   [Full Text] [Related]  

  • 16. Minute to minute neuroendocrine control of a major nonlysosomal pathway of myocardial protein degradation by beta-receptor occupancy.
    Lockwood TD
    Prog Clin Biol Res; 1985; 180():619-22. PubMed ID: 2994092
    [No Abstract]   [Full Text] [Related]  

  • 17. Myocardial fiber necrosis due to intracellular Ca overload-a new principle in cardiac pathophysiology.
    Fleckenstein A; Janke J; Döring HJ; Leder O
    Recent Adv Stud Cardiac Struct Metab; 1974; 4():563-80. PubMed ID: 4468468
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of isoproterenol, propranolol, and D 600 on the de novo synthesis of adenine nucleotides in rat hearts.
    Zimmer HG; Gerlach E
    Recent Adv Stud Cardiac Struct Metab; 1975; 7():131-6. PubMed ID: 1226426
    [No Abstract]   [Full Text] [Related]  

  • 19. Covariance of myocardial cyclic AMP and calcium during beta-adrenergic stimulation in vivo.
    Bloom S; Sweat FW
    Res Commun Chem Pathol Pharmacol; 1974 Jul; 8(3):505-14. PubMed ID: 4152820
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological and metabolic studies with propranolol in man.
    Conolly ME; Paterson JW; Dollery CT; Hayes A; Cooper RG
    Clin Sci; 1970 Feb; 38(2):10P. PubMed ID: 5416143
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.